Researcher:
Abdel-Rahman, Sama Mahmoud

Loading...
Profile Picture
ORCID

Organizational Unit

Job Title

Undergraduate Student

First Name

Sama Mahmoud

Last Name

Abdel-Rahman

Name

Name Variants

Abdel-Rahman, Sama Mahmoud
Abdel-Rahman, Sama

Email Address

Birth Date

Search Results

Now showing 1 - 1 of 1
  • Placeholder
    Publication
    Understanding the role of sex hormones in cardiovascular kidney metabolic syndrome: toward personalized therapeutic approaches
    (MDPI, 2024) Gaipov, Abduzhappar; Covic, Andreea; Soler, Maria Jose; Covic, Adrian; Güldan, Mustafa; Ünlü, Selen; Abdel-Rahman, Sama Mahmoud; Özbek, Laşin; Kanbay, Mehmet; School of Medicine; Graduate School of Health Sciences
    Cardiovascular kidney metabolic (CKM) syndrome represents a complex interplay of cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic comorbidities, posing a significant public health challenge. Gender exerts a critical influence on CKM syndrome, affecting the disease severity and onset through intricate interactions involving sex hormones and key physiological pathways such as the renin-angiotensin system, oxidative stress, inflammation, vascular disease and insulin resistance. It is widely known that beyond the contribution of traditional risk factors, men and women exhibit significant differences in CKM syndrome and its components, with distinct patterns observed in premenopausal women and postmenopausal women compared to men. Despite women generally experiencing a lower incidence of CVD, their outcomes following cardiovascular events are often worse compared to men. The disparities also extend to the treatment approaches for kidney failure, with a higher prevalence of dialysis among men despite women exhibiting higher rates of CKD. The impact of endogenous sex hormones, the correlations between CKM and its components, as well as the long-term effects of treatment modalities using sex hormones, including hormone replacement therapies and gender-affirming therapies, have drawn attention to this topic. Current research on CKM syndrome is hindered by the scarcity of large-scale studies and insufficient integration of gender-specific considerations into treatment strategies. The underlying mechanisms driving the gender disparities in the pathogenesis of CKM syndrome, including the roles of estrogen, progesterone and testosterone derivatives, remain poorly understood, thus limiting their application in personalized therapeutic interventions. This review synthesizes existing knowledge to clarify the intricate relationship between sex hormones, gender disparities, and the progression of CVD within CKM syndrome. By addressing these knowledge gaps, this study aims to guide future research efforts and promote tailored approaches for effectively managing CKD syndrome.